Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Breast Carcinoma In Situ 1Brain Neoplasms 1

Interventions

Specimen Handling 9Tamoxifen 8Radiotherapy 6exemestane 3Radiation Dose Hypofractionation 3Radiation 3Letrozole 3Anastrozole 3Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Patient Navigation 2Observation 2Metformin 2Mastectomy 2Magnetic Resonance Spectroscopy 2Genetic Testing 2Biopsy 2trastuzumab biosimilar HLX02 1ruxolitinib 1poly ICLC 1palbociclib 1fezolinetant 1elacestrant 1afimoxifene 1abemaciclib 1Trastuzumab 1Testosterone 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × Mass Spectrometry × 1 year × Clear all
NCT00898508 2025-06-25

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

City of Hope Medical Center

Completed
563 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡